Evidence map›Paper›PMID 41167843›Full record

ArticleMethods in enzymology2025

A metallophotoredox strategy for biocatalytic radical C-N

Jinyan Rui, Xinpeng Mu, Xiongyi Huang

Abstract read
In one paragraph

Article in Methods in enzymology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jinyan RuiDepartment of Chemistry, Johns Hopkins University, Baltimore, MD, United States.
Xinpeng MuDepartment of Chemistry, Rice University, BioScience Research Collaborative, Houston, TX, United States.
Xiongyi HuangDepartment of Chemistry, Johns Hopkins University, Baltimore, MD, United States. Electronic address: xiongyi@jhu.edu.

Funding

A Chemo-Mimetic Platform to Reprogram Metalloenzymes for Non-Natural Biocatalytic C-H Functionalization ReactionsR35GM147639 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Xiongyi Huang · 2022 to 2026
$2.1M
NIGMS NIH HHS R35 GM147639
6 · The paper itself

Abstract

Metallophotoredox catalysis, an approach that combines photoredox and transition metal catalysis, has emerged as a powerful strategy in modern synthetic chemistry. This dual-catalyst system takes advantage of the broad mechanisms of photocatalysts for substrate activation and the capabilities of transition metal complexes to control reactive radical species. Its modular nature allows each catalytic component to be independently tuned for desired reactivity and selectivity. Despite its significance on synthetic methodologies, biocatalytic analogs of metallophotoredox catalysis remain largely unexplored. To bridge this gap, our group has recently discovered that several nonheme iron enzymes can be combined with synthetic photocatalysts such as eosin Y and fluorescein to enable radical generation from redox-active NHPI esters. The resulting substrate radicals can then be selectively intercepted by the enzymes to promote enantioselective transformations. Particularly, we have successfully repurposed a nonheme iron enzyme, (4-hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis (SavHPPD), to catalyze enantioselective photoredox decarboxylative C-N

Indexed as

DioxygenasesBiocatalysisEosine Yellowish-(YS)Free RadicalsOxidation-ReductionPhotochemical ProcessesStreptomycesDioxygenasesEosine Yellowish-(YS)Free RadicalsAzidationDecarboxylationMetallophotoredox catalysisNonheme iron enzymesThiocyanation

Identifiers

PMID41167843
PMCPMC13229595

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.